Aldeyra Therapeutics, Inc. (ALDX) announced it received a notice from Nasdaq indicating that the company is not in compliance with the minimum bid price requirement for continued listing. The notice was issued because the closing bid price of the company's common stock was below $1.00 per share for the last 30 consecutive business days.

Key Details

  • Reason for Notice: Failure to maintain the $1.00 minimum bid price as required by Nasdaq Listing Rule 5550(a)(2).
  • Compliance Period: The company has an initial 180-day period, until May 17, 2027, to regain compliance.
  • Requirement to Regain Compliance: The stock's closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days within the compliance period.
  • Immediate Impact: The notice has no immediate effect on the listing of the company's common stock, which continues to trade on The Nasdaq Capital Market under the symbol ALDX.